Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 70.2B | 73.6B | 67.7B | 67.2B |
| Cost of revenue | 57.2B | 59.3B | 54.8B | 54.1B |
| Gross profit | 13.0B | 14.4B | 13.0B | 13.1B |
| Operating expense | ||||
| Research & development | 248.9M | 957.5M | — | — |
| Selling general and admin | 2.5B | 4.5B | 8.2B | 8.0B |
| Other operating expenses | 784.4M | 1.2B | — | — |
| Operating income | 4.9B | 3.4B | 4.8B | 5.1B |
| Non operating interest income | ||||
| Income | 153.5M | 253.3M | 244.2M | 239.5M |
| Expense | 1.8B | 1.7B | 1.4B | 1.4B |
| Other income expense | — | — | — | — |
| Pretax income | 3.7B | 1.9B | 4.3B | 4.4B |
| Tax provision | 1.2B | -42.6M | 1.3B | 1.2B |
| Net income | 2.5B | 1.9B | 3.0B | 3.2B |
| Basic EPS | 2.1 | — | 2.4 | 2.6 |
| Diluted EPS | 2.1 | — | 2.4 | 2.6 |
| Basic average shares | 1.1B | — | 1.2B | 1.2B |
| Diluted average shares | 1.1B | — | 1.2B | 1.2B |
| EBITDA | 9.9B | 9.1B | 9.9B | 10.1B |
| Net income from continuing op. | 3.7B | 1.9B | 4.3B | 4.4B |
| Minority interests | -93.1M | -69.9M | -176.4M | -146.2M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |